Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2
暂无分享,去创建一个
[1] L. Ratner,et al. Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants , 1991, Journal of virology.
[2] R. Gallo,et al. Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication , 1991, Journal of virology.
[3] J. Sodroski,et al. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein , 1991, Journal of virology.
[4] B. Moss,et al. Synthesis, oligomerization, and biological activity of the human immunodeficiency virus type 2 envelope glycoprotein expressed by a recombinant vaccinia virus. , 1990, Virology.
[5] E. Freed,et al. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Sodroski,et al. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants , 1990, Journal of virology.
[7] E. Tschachler,et al. Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope , 1990, Journal of virology.
[8] T. Klimkait,et al. A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations. , 1989, Virology.
[9] P. Earl,et al. Identification of the fusion peptide of primate immunodeficiency viruses. , 1989, Science.
[10] L. Jagodzinski,et al. Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[11] B. Chesebro,et al. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity , 1988, Journal of virology.
[12] J. Sodroski,et al. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. , 1987, Science.
[13] W. Gallaher,et al. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus , 1987, Cell.
[14] K. Steimer,et al. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein , 1986, Nature.
[15] F. Brun-Vézinet,et al. Isolation of a new human retrovirus from West African patients with AIDS. , 1986, Science.
[16] J. Lifson,et al. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. , 1986, Science.
[17] T. Waldmann,et al. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. , 1985, The New England journal of medicine.
[18] Y. Vaishnav,et al. The biochemistry of AIDS. , 1991, Annual review of biochemistry.
[19] M. Waxham,et al. Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins. , 1987, AIDS research and human retroviruses.
[20] J. Sodroski,et al. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity , 1986, Nature.